Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality.
D000928:Antidepressive Agents / Q000627:therapeutic use; D003024:Clozapine / Q000627:therapeutic use; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy; D004298:Dopamine / Q000502:physiology; D004565:Electroconvulsive Therapy; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D001523:Mental Disorders / Q000150:complications*; D009627:Nomifensine / Q000627:therapeutic use; D009661:Nortriptyline / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications* / Q000523:psychology; D010551:Personality; D011618:Psychotic Disorders / Q000150:complications; D012701:Serotonin / Q000378:metabolism; D014364:Tryptophan / Q000494:pharmacology
D000928:Antidepressive Agents; D009627:Nomifensine; D012701:Serotonin; D007980:Levodopa; D014364:Tryptophan; D009661:Nortriptyline; D003024:Clozapine; D004298:Dopamine; D006719:Homovanillic Acid